Experimental, cancer-induced retinopathy

C. E. Thirkill, R. C. Tait, A. M. Roth, John L Keltner

Research output: Contribution to journalArticle

Abstract

Purpose: Vision loss occurring in association with cancers predominates in patients with small cell carcinoma of the lung (SCCL). The pathogenesis of some types of paraneoplastic retinopathy may be founded in autoimmunity, such as that previously proposed to explain the cause of the CAR syndrome, in which lung cancer cells expressing the CAR photoreceptor autoantigen, are considered the cause of the immune reaction which characterizes this form of cancer-induced blindness. An extended search for similar immunologic connections has uncovered a second example of this phenomenon, involving a cancer culture expressing a novel retinal antigen. This study inquired into the pathologic significance of the expression of this 'tumor-associated retinal antigen', as a possible trigger mechanism for the induction of autoimmune reactions affecting the eye. Methods: Cultures of SCCL (American Type Culture Collection) were evaluated for the expression of retinal antigens by propagation intraperitoneally in Lewis rats and evaluation of the induced immune response. Results: A culture of SCCL was found to be expressing a single retinal antigen, identified by the production of corresponding antibodies by the recipient rats in which the culture was introduced. Histologic examination of eyes of these rats revealed indications of retinal decay. Conclusions: Structural alterations to the retina can be induced experimentally in Lewis rats through the intraperitoneal cultivation of a SCCL recognized to be expressing a retinal antigen. This model of 'Experimental, Cancer Induced Blindness' provides further evidence of an autoimmune pathogenesis in certain forms of paraneoplastic retinopathy, demonstrating an immunologic pathway through which vision loss can occur as a remote effect of cancer, with eyesight declining as a result of a cancer-evoked autoimmune retinopathy.

Original languageEnglish (US)
JournalInvestigative Ophthalmology and Visual Science
Volume37
Issue number3
StatePublished - Feb 15 1996

Fingerprint

Small Cell Lung Carcinoma
Antigens
Neoplasms
Blindness
Retinal Neoplasms
Autoantigens
Autoimmunity
Antibody Formation
Retina
Lung Neoplasms
Theoretical Models

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Experimental, cancer-induced retinopathy. / Thirkill, C. E.; Tait, R. C.; Roth, A. M.; Keltner, John L.

In: Investigative Ophthalmology and Visual Science, Vol. 37, No. 3, 15.02.1996.

Research output: Contribution to journalArticle

Thirkill, C. E. ; Tait, R. C. ; Roth, A. M. ; Keltner, John L. / Experimental, cancer-induced retinopathy. In: Investigative Ophthalmology and Visual Science. 1996 ; Vol. 37, No. 3.
@article{13f1d73949a643ac96b2364e69747fd1,
title = "Experimental, cancer-induced retinopathy",
abstract = "Purpose: Vision loss occurring in association with cancers predominates in patients with small cell carcinoma of the lung (SCCL). The pathogenesis of some types of paraneoplastic retinopathy may be founded in autoimmunity, such as that previously proposed to explain the cause of the CAR syndrome, in which lung cancer cells expressing the CAR photoreceptor autoantigen, are considered the cause of the immune reaction which characterizes this form of cancer-induced blindness. An extended search for similar immunologic connections has uncovered a second example of this phenomenon, involving a cancer culture expressing a novel retinal antigen. This study inquired into the pathologic significance of the expression of this 'tumor-associated retinal antigen', as a possible trigger mechanism for the induction of autoimmune reactions affecting the eye. Methods: Cultures of SCCL (American Type Culture Collection) were evaluated for the expression of retinal antigens by propagation intraperitoneally in Lewis rats and evaluation of the induced immune response. Results: A culture of SCCL was found to be expressing a single retinal antigen, identified by the production of corresponding antibodies by the recipient rats in which the culture was introduced. Histologic examination of eyes of these rats revealed indications of retinal decay. Conclusions: Structural alterations to the retina can be induced experimentally in Lewis rats through the intraperitoneal cultivation of a SCCL recognized to be expressing a retinal antigen. This model of 'Experimental, Cancer Induced Blindness' provides further evidence of an autoimmune pathogenesis in certain forms of paraneoplastic retinopathy, demonstrating an immunologic pathway through which vision loss can occur as a remote effect of cancer, with eyesight declining as a result of a cancer-evoked autoimmune retinopathy.",
author = "Thirkill, {C. E.} and Tait, {R. C.} and Roth, {A. M.} and Keltner, {John L}",
year = "1996",
month = "2",
day = "15",
language = "English (US)",
volume = "37",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "3",

}

TY - JOUR

T1 - Experimental, cancer-induced retinopathy

AU - Thirkill, C. E.

AU - Tait, R. C.

AU - Roth, A. M.

AU - Keltner, John L

PY - 1996/2/15

Y1 - 1996/2/15

N2 - Purpose: Vision loss occurring in association with cancers predominates in patients with small cell carcinoma of the lung (SCCL). The pathogenesis of some types of paraneoplastic retinopathy may be founded in autoimmunity, such as that previously proposed to explain the cause of the CAR syndrome, in which lung cancer cells expressing the CAR photoreceptor autoantigen, are considered the cause of the immune reaction which characterizes this form of cancer-induced blindness. An extended search for similar immunologic connections has uncovered a second example of this phenomenon, involving a cancer culture expressing a novel retinal antigen. This study inquired into the pathologic significance of the expression of this 'tumor-associated retinal antigen', as a possible trigger mechanism for the induction of autoimmune reactions affecting the eye. Methods: Cultures of SCCL (American Type Culture Collection) were evaluated for the expression of retinal antigens by propagation intraperitoneally in Lewis rats and evaluation of the induced immune response. Results: A culture of SCCL was found to be expressing a single retinal antigen, identified by the production of corresponding antibodies by the recipient rats in which the culture was introduced. Histologic examination of eyes of these rats revealed indications of retinal decay. Conclusions: Structural alterations to the retina can be induced experimentally in Lewis rats through the intraperitoneal cultivation of a SCCL recognized to be expressing a retinal antigen. This model of 'Experimental, Cancer Induced Blindness' provides further evidence of an autoimmune pathogenesis in certain forms of paraneoplastic retinopathy, demonstrating an immunologic pathway through which vision loss can occur as a remote effect of cancer, with eyesight declining as a result of a cancer-evoked autoimmune retinopathy.

AB - Purpose: Vision loss occurring in association with cancers predominates in patients with small cell carcinoma of the lung (SCCL). The pathogenesis of some types of paraneoplastic retinopathy may be founded in autoimmunity, such as that previously proposed to explain the cause of the CAR syndrome, in which lung cancer cells expressing the CAR photoreceptor autoantigen, are considered the cause of the immune reaction which characterizes this form of cancer-induced blindness. An extended search for similar immunologic connections has uncovered a second example of this phenomenon, involving a cancer culture expressing a novel retinal antigen. This study inquired into the pathologic significance of the expression of this 'tumor-associated retinal antigen', as a possible trigger mechanism for the induction of autoimmune reactions affecting the eye. Methods: Cultures of SCCL (American Type Culture Collection) were evaluated for the expression of retinal antigens by propagation intraperitoneally in Lewis rats and evaluation of the induced immune response. Results: A culture of SCCL was found to be expressing a single retinal antigen, identified by the production of corresponding antibodies by the recipient rats in which the culture was introduced. Histologic examination of eyes of these rats revealed indications of retinal decay. Conclusions: Structural alterations to the retina can be induced experimentally in Lewis rats through the intraperitoneal cultivation of a SCCL recognized to be expressing a retinal antigen. This model of 'Experimental, Cancer Induced Blindness' provides further evidence of an autoimmune pathogenesis in certain forms of paraneoplastic retinopathy, demonstrating an immunologic pathway through which vision loss can occur as a remote effect of cancer, with eyesight declining as a result of a cancer-evoked autoimmune retinopathy.

UR - http://www.scopus.com/inward/record.url?scp=33750190699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750190699&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750190699

VL - 37

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 3

ER -